Pleiotropic Effects of Mitiglinide in Type 2 Diabetes Mellitus

By Konya H   Miuchi M   Konishi K   Nagai E   Ueyama T   Kusunoki Y   Kimura Y   Nakamura Y   Ishikawa T   Inokuchi C   Katsuno T   Hamaguchi T   Miyagawa J   Namba M  

The Journal of International Medical Research, Vol. 37, Iss. 6, 2009-11 ,pp. : 1904-1912

Field House Publishing

Access to resources Recommend Favorite

Mitiglinide/voglibose fixed-dose combination improves postprandial glycemic excursions in Japanese patients with type 2 diabetes mellitus

By Ono Yuri   Kameda Hiraku   Cho Kyu Yong  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 4, 2013-03 ,pp. : 361-370

Informa Healthcare

Access to resources Recommend Favorite

Tighter control of postprandial hyperglycemia with mitiglinide/voglibose fixed-dose combination in Japanese patients with type 2 diabetes mellitus

By Inoue Masahiro  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 16, 2012-11 ,pp. : 2257-2268

Informa Healthcare

Access to resources Recommend Favorite

Multicentre, Double-blind, Randomized Study of Mitiglinide Compared with Nateglinide in Type 2 Diabetes Mellitus Patients in China

By Gao X    

The Journal of International Medical Research, Vol. 37, Iss. 3, 2009-05 ,pp. : 812-821

Field House Publishing

Access to resources Recommend Favorite

Comparison of the hypoglycemic effect of sitagliptin versus the combination of mitiglinide and voglibose in drug-naïve Japanese patients with type 2 diabetes

By Ohta Akio   Ohshige Toshihiko   Sakai Kensuke   Nakamura Yuta   Tenjin Ayumi   Tsukiyama Shuichi   Terashima Yuko   Matsubara Fumiaki   Kawata Takehiro   Nagai Yoshio   Tanaka Yasushi  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 17, 2013-12 ,pp. : 2315-2322

Informa Healthcare

Access to resources Recommend Favorite